• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Catabasis Pharmaceuticals

edit

Catabasis Pharmaceuticals, Inc. is a biopharmaceutical company located in Cambridge, Massachusetts focused on the discovery and development of innovative drugs to treat inflammatory conditions. There platform technology enables the discovery and development of small molecules that simultaneously and specifically target pathways in the inflammatory response. The Catabasis platform will lead to the development of novel mechanism of action therapies to safely and effectively treat inflammatory diseases.

Recent Milestones

edit

• 
  Catabasis Pharmaceuticals received $9M in Venture Round funding. (2/6/13)
  Posted 2/6/13 at 8:32pm via fiercebiotech.com
• 
  Catabasis Pharmaceuticals received $120k in Grant funding. (4/4/12)
  Posted 4/4/12 at 9:37pm via masshightech.com
• 
  Catabasis Pharmaceuticals received $8M in Series A funding. (12/13/11)
  Posted 12/13/11 at 7:37pm via catabasispharma.com
• 
  Catabasis Pharmaceuticals received $14.5M in Series A funding. (12/8/10)
  Posted 12/8/10 at 6:53pm via fiercebiotech.com
• 
  Catabasis Pharmaceuticals received $39M in Series A funding. (4/21/10)
  Posted 4/21/10 at 6:05pm via fiercebiotech.com
• 
  Catabasis Pharmaceuticals received $2M in Debt funding. (1/18/10)
  Posted 1/20/10 at 12:19am via masshightech.com
• 
  Catabasis Pharmaceuticals added Jill C. Milne as CEO.
  Posted 10/20/10 at 10:15pm
• 
  Catabasis Pharmaceuticals added Michael Curtis as Vice President, Product Development.
  Posted 10/20/10 at 10:15pm

Videos

Screenshots

edit

Above: Home Page
Uploaded: 1/20/10

Sources

1. Catabasis Pharma pulls in $2M (masshightech.com) [edit]
2. Catabasis lands $39M Series A for diabetes programs (fiercebiotech.com) [edit]
3. Catabasis lands $14.5M tranche for Omega-3 drug development (fiercebiotech.com) [edit]
4. Catabasis Pharmaceuticals Announces $8 Million Series A Extension Financing (catabasispharma.com) [edit]
5. Catabasis gets $120K from MDA to test compounds (masshightech.com) [edit]
6. Catabasis raises $9M for PhII-ready drug development program (fiercebiotech.com) [edit]